This post was originally published on this site
Esperion Therapeutics (NASDAQ:ESPR) 62% LOWER; reports Daiichi Sankyo disagrees with the company’s assessment that CLEAR Outcomes data would support milestone payments.
LivePerson Inc (NASDAQ:LPSN) 40% LOWER; reported Q4 EPS of ($0.55), may not compare to the analyst estimate of $0.12. Revenue for the quarter came in at $122.5 million versus the consensus estimate of $126.93M. LivePerson sees FY2023 revenue of $395-410M, versus the consensus of $555.7M.
Uipath Inc (NYSE:PATH) 12% HIGHER; reported Q4 EPS of $0.15, $0.09 better than the analyst estimate of $0.06. Revenue for the quarter came in at $308.5M versus the consensus estimate of $278.64M. UiPath Inc. sees Q1 2024 revenue of $270-270M, versus the consensus of $269.14M. UiPath Inc. sees FY2024 revenue of $1.253-1.258 billion, versus the consensus of $1.21B.
CVR Energy Inc (NYSE:CVI) 7% HIGHER; will replace Atlas Air (NASDAQ:AAWW) in the S&P SmallCap 600.
Adobe Systems (NASDAQ:ADBE) 5% HIGHER; reported Q1 EPS of $3.80, $0.12 better than the analyst estimate of $3.68. Revenue for the quarter came in at $4.66B versus the consensus estimate of $4.62B. Adobe Systems sees FY2023 EPS of $15.30-$15.60, versus the consensus of $15.31. Adobe Systems sees Q2 2023 EPS of $3.75-$3.80, versus the consensus of $3.76. Adobe Systems sees Q2 2023 revenue of $4.75-4.78B, versus the consensus of $4.76B.
Enovix Corp (NASDAQ:ENVX) 5% HIGHER; Chairman, Thurman John Rodgers, bought $1.35M in stock.
Certara Inc (NASDAQ:CERT) 4% HIGHER; will replace Exponent (NASDAQ:EXPO) in the S&P SmallCap 600.
Five Below (NASDAQ:FIVE) 4% LOWER; reported Q4 EPS of $3.07, $0.01 better than the analyst estimate of $3.06. Revenue for the quarter came in at $1.12B versus the consensus estimate of $1.11B. Five Below sees Q1 2024 EPS of $0.59-$0.65, versus the consensus of $0.68. Five Below sees Q1 2024 revenue of $723-735M, versus the consensus of $731M. Five Below sees FY2024 EPS of $5.25-$5.76, versus the consensus of $5.67. Five Below sees FY2024 revenue of $3.49-3.59B, versus the consensus of $3.58B.
